Are you Dr. Sims?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Blk 12, Neurology Associates
Boston, MA 02114Phone+1 617-724-7413Fax+1 617-726-6991
Summary
- Dr. John Sims, MD is a neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Minnesota.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1999 - 2002
- Geisel School of Medicine at DartmouthClass of 1994
Certifications & Licensure
- MN State Medical License 2014 - 2017
Clinical Trials
- Safety Study of Dantrolene to Treat Cerebral Vasospasm After Subarachnoid Hemorrhage Start of enrollment: 2007 Jul 01
Publications & Presentations
PubMed
- 65 citationsTrial of Solanezumab in Preclinical Alzheimer's Disease.Reisa A Sperling, Michael C Donohue, Rema Raman, Michael S Rafii, Keith Johnson
The New England Journal of Medicine. 2023-09-21 - 57 citationsClinical examination for prognostication in comatose cardiac arrest patients.David M. Greer, Jingyun Yang, Patricia D. Scripko, John R. Sims, Sydney S. Cash
Resuscitation. 2013-11-01 - 89 citationsMulticolored stain-free histopathology with coherent Raman imagingChristian W. Freudiger, Rolf Pfannl, Daniel A. Orringer, Brian G. Saar, Minbiao Ji
Laboratory Investigation; a Journal of Technical Methods and Pathology. 2012-08-20
Press Mentions
- What Drugmakers Did Not Tell Volunteers in Alzheimer’s TrialsOctober 23rd, 2024
- Donanemab Analyses Suggest Benefits for Select Alzheimer's PatientsSeptember 12th, 2022
- What Happened with a Once-Promising Alzheimer's DrugNovember 25th, 2019
- Join now to see all
Grant Support
- Ischemic Injury And Sonic Hedgehog'S Role Neural Progenitor ResponseNational Institute Of Neurological Disorders And Stroke2007–2009